Healthy Q2 For Apollo Hospitals | New Bed Additions To Start Contributing To EBITDA By 2027, Says Co
CNBC-TV18 · 05 Nov 2026 · 13 min
Management interview of Apollo Hospitals Enterprise Ltd (APOLLOHOSP), with 9 key numbers discussed.
- Suneeta Reddy, MD, Apollo Hospitals
Apollo Hospitals reported a 23% year-on-year increase in total revenue to Rs 3,900 cr for Q2 FY27, with EBITDA reaching Rs 937 cr. While established hospital margins remained healthy at 26%, new bed additions incurred initial losses of Rs 36 cr, which are expected to break even and contribute to EBITDA within a year. Management maintained its hospital revenue growth guidance of 18-20% due to upcoming holidays. Suneeta Reddy noted that the proposed oncology drug margin cap will have limited impact as Apollo provides end-to-end care.
